Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Prostate Carcinoma: early-phase trial registry
31 of 60 indexed Prostate Carcinoma trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #235 of 28,707 conditions by registered trial count.
60 US clinical trials · 31 currently recruiting · #235 of 28,707 conditions by registered trial count
Prostate Carcinoma: 60 US clinical trials tracked, 31 recruiting.
Prostate Carcinoma is the subject of 60 registered US clinical trials on ClinicalTrials.gov, 31 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 22 in Phase 1-2 (earlier-stage). The most active sponsor is Jonsson Comprehensive Cancer Center, running 10 of these trials.
Enrollment posture brief
Registry condition prostate-carcinoma
OPEN 31 | RECR 52% | LATE 3 | EARLY 22 | RANK #235 | SPON 10
Volume-matched condition peers
Nearest open-share peer: Cutaneous Melanoma (52% recruiting · 31 trials)
Prostate Carcinoma lists 31 open slots (52% of 60 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Prostate Carcinoma on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Prostate Carcinoma is recruiting above its size-band peers.
31 of 60 indexed trials (51.7%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Prostate Carcinoma research.
Jonsson Comprehensive Cancer Center accounts for 10 of 60 trials (16.7%). 20 distinct sponsors appear on at least one study for this condition label.
-
Typical Prostate Carcinoma enrolment sits around 96 participants.
Median target enrolment is 96 among the 60 trials that report a genuine target (sentinel values excluded). 33 of those (55%) plan for fewer than 100 participants.
-
Prostate Carcinoma research is mostly interventional.
52 interventional and 8 observational studies make up this index (86.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
60 total, page 1 of 2
Investigation Into Detection of Prostate Cancer Using Voided Urine (Prostate VPAC)
Thomas Jefferson University
NCT04788277
Reduction of Gastrointestinal Toxicity in Prostate Cancer by Proton Spot Placement
Covenant Health Cancer Center
NCT06200259
Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
University of Washington
NCT04472338
EMBRACE: Exercising Together
OHSU Knight Cancer Institute
NCT06049355
Longitudinal Advanced Prostate Cancer Cohort (LAPCC)
University of Southern California
NCT06067295
Integrating Quantitative MRI and Artificial Intelligence to Improve Prostate Cancer Classification
Jonsson Comprehensive Cancer Center
NCT04765150
Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors, iLIVE
OHSU Knight Cancer Institute
NCT06011499
Building Community Living Labs in Black Communities to Advance Prostate Health Equity and Reduce Prostate Cancer Disparities in Black Men
Mayo Clinic
NCT06541210
Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers
City of Hope Medical Center
NCT05519878
Bright White Light Therapy in Reducing Cancer-Related Fatigue and Depression in Advanced Prostate Cancer Patients Undergoing Treatment With ADT Combination Therapy
City of Hope Medical Center
NCT05869682
Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate Cancer
M.D. Anderson Cancer Center
NCT04947254
Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases
Mayo Clinic
NCT06788886
MRI-Based Machine Learning Approach Versus Radiologist MRI Reading for the Detection of Prostate Cancer, The PRIMER Trial
University of Southern California
NCT07162194
Radiation Therapy With RapidPlan Knowledge-based Planning vs Human-Driven Planning for Treatment of Prostate Cancer
Mayo Clinic
NCT06625034
Brain and Pelvic Floor Muscle Activity of Patients Who Had or Are Undergoing Robot-Assisted Radical Prostatectomy
Roswell Park Cancer Institute
NCT04646434
MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Low to Intermediate Grade Prostate Cancer
Mayo Clinic
NCT05438563
An Investigational Scan (18F-rhPSMA-7.3 PET-mpMRI) for Targeted Prostate Biopsy Using TRUS-MR Fusion Technique
Emory University
NCT06865768
Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT)
Jonsson Comprehensive Cancer Center
NCT06216249
An Investigational Scan (Flotufolastat F 18 PET/CT) for Detecting Residual or Recurrent Disease in Patients Who Completed Focal Therapy for Prostate Cancer.
Jonsson Comprehensive Cancer Center
NCT07185165
A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients
University of Michigan Rogel Cancer Center
NCT07291414
Community-Based Health Coach for Access to Germline Genetic Testing Among African American Men With Prostate Cancer
University of California, San Francisco
NCT04763980
Screening and Staging of Benign vs Malignant Pelvic Abnormalities
Mayo Clinic
NCT07407959
Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT Trial
City of Hope Medical Center
NCT07202247
Oral Cryotherapy to Decrease Taste Changes in Prostate Cancer Patients Receiving Taxane Chemotherapy
City of Hope Medical Center
NCT07218718
Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy
Shehzad Basaria, M.D.
NCT06957691
iCCaRE Consortium Pilot Project 1: Feasibility of a Point of Prostate Cancer Diagnosis Intervention for Newly Diagnosed Black Men
Mayo Clinic
NCT06535802
Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer
University of California, San Francisco
NCT05766371
99mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer
Jonsson Comprehensive Cancer Center
NCT04857502
Comparing a New PSMA Imaging Agent to MRI for Detecting Prostate Cancer, BEACON Trial
Jonsson Comprehensive Cancer Center
NCT07164027
[18F]-rhPSMA PET-CT Imaging Performance in Patients With Prostate Cancer
City of Hope Medical Center
NCT06580015
Exploring the Potential of Robotic Telesurgery in Remote Settings
AdventHealth
NCT07130708
Screening for Prostate Cancer in Older Patients (PLCO Screening Trial)
National Cancer Institute (NCI)
NCT00002540
Long-Term Follow-Up in Patients With Prostate Cancer After Surgery
City of Hope Medical Center
NCT03035500
Multiparametric MRI in Evaluating Cancer Stage and Helping Treatment Planning in Patients With Prostate Cancer
ECOG-ACRIN Cancer Research Group
NCT03697148
HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics
City of Hope Medical Center
NCT04905082
To Evaluate if Green Tea Can be Effective in Reducing the Progression of Prostate Cancer in Men on Close Monitoring
ECOG-ACRIN Cancer Research Group
NCT04597359
Survivorship Care Plans and Telehealth Education for the Improvement of Access to Cancer Survivorship, the IMPACT Study
Fred Hutchinson Cancer Center
NCT04081779
Methylphenidate and Exercise in Reducing Cancer-Related Fatigue in Patients With Prostate Cancer
M.D. Anderson Cancer Center
NCT03772834
Evaluation of the Impact of Empty Versus Full Bladder in Patients With Prostate Cancer, RELIEF Trial
Mayo Clinic
NCT06037863
Enhanced Genetic Awareness and Genetic Evaluation for Men Through Technology, ENGAGEMENT Study
Thomas Jefferson University
NCT04789018
Determination of Baseline Levels for Prostate Cancer-Derived Extracellular Vesicles Following Local Treatment of Prostate Cancer
Mayo Clinic
NCT06326216
Magnetic Resonance Whole Body Diffusion-Weighted Imaging in Finding Bone or Lymph Node Metastasis in Participants With High-Risk Prostate Cancer
M.D. Anderson Cancer Center
NCT03085043
Study of Olaparib Maintenance Following Cabazitaxel-Carbo in Men With AVPC
M.D. Anderson Cancer Center
NCT03263650
Micro-Ultrasound for the Detection and Localization of Prostate Cancer Tumors in Patients Undergoing Radical Prostatectomy
Jonsson Comprehensive Cancer Center
NCT04299620
Prostate Cancer Diagnosis by Multiparametric Ultrasound (Wholemount)
Thomas Jefferson University
NCT05336786
An Investigational Scan (MRI With Dixon Based Sequences) in Detecting Prostate Cancer
M.D. Anderson Cancer Center
NCT05047965
RefleXion PET/CT Imaging Performance in Patients With Prostate Cancer
City of Hope Medical Center
NCT05470699
Novel Synthetic T2W MR Imaging and Spin Parameter Mapping Techniques for Screening Prostate Cancer
M.D. Anderson Cancer Center
NCT05055843
Image-Guided (68Ga-PSMA-11 PET/CT) Prostate Biopsy for the Diagnosis of Prostate Cancer in Men With Prior Negative/Inconclusive Biopsy
Jonsson Comprehensive Cancer Center
NCT05160597
Prospective Exploratory Study of FAPi PET/CT in Prostate Cancer With Histopathology Validation
Jonsson Comprehensive Cancer Center
NCT04457232
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 7 |
| Phase 2 | 15 |
| Phase 3 | 3 |
Top Sponsors
Named interventions
Most-linked intervention names on Prostate Carcinoma records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Prostate Carcinoma trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Prostate Carcinoma page
60 registered trials, 31 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 31 Prostate Carcinoma trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Jonsson Comprehensive Cancer Center sponsors the most Prostate Carcinoma trials on record, review their full trial history before evaluating a specific study. See Jonsson Comprehensive Cancer Center's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Prostate Carcinoma condition card totals 60 registered trials; most-linked intervention Questionnaire Administration; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.